Blackey Brent G 4
4 · Cardiovascular Systems Inc · Filed May 8, 2018
Insider Transaction Report
Form 4
Blackey Brent G
Director
Transactions
- Sale
Common Stock
2018-05-04$26.73/sh−16,264$434,737→ 93,465 total
Holdings
- 2,095
Restricted Stock Units
From: 2019-09-01Exp: 2019-09-01→ Common Stock (2,095 underlying) - 2,541
Restricted Stock Units
From: 2019-08-15Exp: 2019-08-15→ Common Stock (2,541 underlying) - 77,273
Restricted Stock Units
→ Common Stock (77,273 underlying) - 2,855
Restricted Stock Units
From: 2018-09-01Exp: 2018-09-01→ Common Stock (2,855 underlying) - 4,029
Restricted Stock Units
→ Common Stock (4,029 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.55 to $27.02 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc. ("CSI"), any security holder of CSI, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
- [F3]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning on the payment date.
- [F4]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,008 shares on September 30, 2017 and 1,007 shares on each of December 31, 2017, March 31, 2018 and June 30, 2018.